|
 |
CozaarThis page contains recent news articles, when available, and an overview of Cozaar but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Cozaar (when available) Losartan is the first of a class of antihypertensive agents called angiotensin II (AG II) receptor antagonists. It is, along with its longer acting active metabolite (E-3174), a specific and selective AT1 receptor antagonist. Losartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor found in many tissues, (e.g., vascular smooth muscle, adrenal gland). For the treatment of hypertension Mechanism Of Action: Losartan and its longer acting active metabolite (E-3174) interfere with the binding of angiotensin II to the angiotensin II AT1-receptor by, themselves, binding reversibly to the receptors in vascular smooth muscle and the adrenal gland. As angiotensin II is a vasoconstrictor, which also stimulates the synthesis and release of aldosterone, blockage of its effects results in decreases in systemic vascular resistance. Neither Losartan or its metabolite inhibit the angiotensin converting enzyme, other hormone receptors, or ion channels. News Articles on Losartan Why piling eye drops high can make a lot of sense to Novartis - Jan 4, 2010 Merck's blockbuster blood-pressure treatment, Cozaar, loses protection in the first half of the year. The product earned Merck $861 million in the third ... Times Online Savvy Senior: When it is and when it isn't safe to split pills - Jan 2, 2010 High blood pressure medicines like Monopril, Prinivil, Univasc, Zestril, Avapro and Cozaar. Erectile dysfunction pills, like Viagra, Cialis and Levitra. ... Annapolis Capital Some Brand-Name Patents: Going, Going, Gone in 2010 - Dec 29, 2009 Merck expects hypertension treatments Cozaar and Hyzaar to bring in sales of $3.4 billion to $3.7 billion combined this year. That's about 15% of expected ... Motley Fool Gilead's Phase 3 Train Wreck - Dec 16, 2009 Merck's (NYSE: MRK) Cozaar, or Pfizer's (NYSE: PFE) Norvasc. Besides, a second phase 3 trial would clear up just how bad the side effect profile was. ... Motley Fool Drug treatments for hypertension - Jan 4, 2010 Examples are Lisinopril®, Cozaar®, Atacand®. Diuretics (commonly called water pills), are another drug group that help the body to expel excess fluid and ... NEXT Savvy senior: Often it's OK to split pills - Dec 29, 2009 Pills that are most commonly split include: • High blood pressure medicines like, Monopril, Prinivil, Univasc, Zestril, Avapro and Cozaar. ... The Saratogian Merck Will Mesh With Acquisition - Dec 31, 2009 In 2010, Merck will lose patent protection on two related hypertension drugs — Cozaar and Hyzaar — that together contribute about $3.5 billion to annual ... Investor's Business Daily DuPont sees U.S. economic recovery taking hold - Nov 3, 2009 The bullish outlook comes despite the 2010 loss of patent protection for the blood pressure drugs Cozaar and Hyzaar. The drugs are expected to add $1.1 ... Reuters Fitch lowers Merck ratings after Schering purchase - Nov 4, 2009 Fitch expects the Whitehouse Station, NJ, company's revenue to fall next year after the patent on the blood pressure drug Cozaar expires. ... The Associated Press Merck 3Q Net More Than Triples On Gain; Boosts View - Oct 22, 2009 But sales declined for blood-pressure drugs Cozaar and Hyzaar, and rotavirus vaccine Rotateq. Merck's cervical-cancer vaccine Gardasil continued to decline, ... Wall Street Journal Merck Announces Third-Quarter 2009 Financial Results - Oct 22, 2009 The company is expecting a significant decline in future COZAAR/HYZAAR sales since these medicines will lose marketing exclusivity in the US and major ... Reuters DuPont Sales Trail Analysts' Estimates as Prices Drop - Oct 20, 2009 Profit from hypertension drugs Cozaar and Hyzaar rose 2.3 percent to $266 million, accounting for 35 percent of segment earnings. ... Bloomberg Novartis:Diovan Decline To Accelerate On Generic Cozaar Launch - Oct 22, 2009 Cozaar is sold by US drugmaker Merck Inc. (MRK). It will lose patent protection next year. It belongs to the same class of drugs as Diovan. ... EasyBourse.com Fitch Rates DuPont's Senior Unsecured Notes 'A'; Outlook Remains Negative - Nov 5, 2009 ...of the estimated $1 billion in annual pharmaceutical royalties from the hypertension drug Cozaar/Hyzaar in 2009 after US patent expiry in April 2010. ... Business Wire (press release) Highlights From MHS's Q3 Conference Call: Improving FY09 Expectations and ... - Nov 3, 2009 So drugs like Flomax, Cozaar and Hyzaar, they're very strong mail-penetrated accounts in our book. So those are clearly the primary drivers to the growth ... StreetInsider.com (subscription) Double-Digit Growth in a Recession - Oct 21, 2009 ...(NYSE: AZN) Zestril, Merck's (NYSE: MRK) Cozaar, or Pfizer's (NYSE: PFE) Norvasc. Data from a second phase 3 trial is expected in the next few months. ... Motley Fool • India, Brazil decide on case against EU on generics - Oct 23, 2009 The medicines which were detained included losartan, the generic name for Merck & Co's, blood pressure drug Cozaar, which was developed jointly by Merck and ... Institute of International Trade Commercial Insight: Antihypertensives - New fixed dose combinations unable to ... - Oct 30, 2009 Cozaar's and Diovan's patent expiries in the US are expected to alter the structure of the antihypertensive market dramatically. ... PRMinds (press release) Brasil e Ã?ndia entrarão na OMC contra UE por genéricos - Oct 22, 2009 A apreensão de dezembro do ano passado envolveu um carregamento de losartan, o nome genérico da droga da Merck & Co's para pressão Cozaar, ... O Globo æ—¥ ì œë„¤ë¦ ì‹œìž¥ '외ìž?사 진출러시' - Nov 2, 2009 ...pramipexole)ê°€, 2012ë…„ì—” '아리미ë?±ìŠ¤'(Arimidex, anastrozole), 'ì½”ìž?'(Cozaar, losartan), '쎄로켈'(Seroquel, quetiapine), '파리ì—?트'(Pariet, rabeprazole), ... 디지틀보사 ZONAS - América Latina India, Brasil reclaman a UE por drogas genéricas - Oct 22, 2009 El incautamiento de diciembre involucró a un cargamento de losartan, el nombre genérico para el fármaco para la presión sanguÃnea Cozaar, desarrollado en ... Invertia (Argentina) Merck & Co verdreifacht Gewinn dank Anteilsverkauf - Oct 22, 2009 Schlechter lief es dagegen bei dem Blutdruck-Medikamenten "Cozaar" und "Hyzaar". Gleichzeitig bekräftigte die Merck & Co Inc, im Gesamtjahr einen Umsatz von ... manager-magazin.de Cozaar Eyed as Preventive Therapy for Marfan's - Apr 7, 2006 By Michael Smith, 0. BALTIMORE, April 7 - A commonly used anti-hypertensive drug may prevent some of the complications of Marfan's syndrome, including the ... MedPage Today Merck Treats Traders With Good News - Jul 23, 2007 Other popular meds included hypertension drugs Cozaar and Hyzaar. ... He said that Singulair, Cozaar/Hyzaar and Astra Merck also beat his estimates. ... Forbes Merck outlook misses view as dollar strengthens - Dec 4, 2008 The New Jersey-based drugmaker, which also faces looming generic exposure to Singulair and Cozaar, said in October it was slashing 7200 positions, ... Reuters Drug firm's tactics reprimanded - Oct 2, 2006 During the course of the investigation, the ABPI found MSD used Cozaar logos and called the venture the "Cozaar Nurse Audit Programme". ... BBC News Merck Profit Hurt by Vioxx Withdrawal - Jan 31, 2005 Hypertension drugs Cozaar and Hyzaar saw quarterly sales grow 11 percent to $764 million. Although sales of cholesterol fighter Zocor (search) rose 8 ... FOXNews Merck Raises Profit Targets - Jul 20, 2007 Among large, veteran products, the asthma drug Singulair gained 15% to $1.1 billion in sales, and revenue from the blood-pressure medications Cozaar and ... TheStreet.com - TheStreet.com (subscription) Merck Beats, but Offers No Forward Guidance - Jul 21, 2008 Sales of antihypertensive drugs cozaar and hyzaar rose 11% to $941 million in revenue. Sales of type II diabetes treatment Januvia increased to $334 million ... TheStreet.com - TheStreet.com (subscription) Cozaar Overnight Delivery - Jul 17, 2007 ...pharmacology. Pharmacology is not identical with pharmacy, though in common usage the two are at times confused. Contents [hide] * 1 Medicine development ... Sokwanele India's Aurobindo Pharma gets tentative US FDA nod for Merck generic - Aug 21, 2008 ...the US Food and Drug Administration to manufacture and market anti-hypertensive Losartan Potassium tablets, the generic equivalent of Merck's Cozaar. ... Forbes Fitch cuts Merck's debt ratings to "AA-minus" - Feb 16, 2007 These products, Zocor, Fosamax, Cozaar, and Singulair, collectively generated 56 percent of total revenues in 2006, the credit ratings agency said. ... Reuters Merck eyes deals, growth through 2013 - Nov 19, 2008 Company revenue from its hypertension drug Cozaar and asthma drug Singulair will plunge in 2012 because of generic competition for the blockbuster products. ... Reuters GARDEN STATE BRIEFS - Apr 15, 2005 In March, the US Food and Drug Administration approved Cozaar for the same indication. - Reuters Lucent wins contracts Lucent Technologies has won contracts ... Pay-Per-View - Star-Ledger - Factiva, from Dow Jones Teva Announces Tentative Approval for Generic Cozaar(R) Tablets. - May 28, 2006 JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the US Food and Drug Administration has granted tentative approval for ... Free with registration - Business Wire - AccessMyLibrary.com Cozaar.(Used in the treatment of high blood pressure) - Dec 1, 2005 Cozaar is also used to slow the progress of kidney disease caused by type 2 diabetes (the type of diabetes that doesn't require insulin shots). ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Cozaar No Rx Required - Jul 15, 2007 To recoup this outlay pharmaceutical companies may do a number of things:[2] * Carefully research the Cozaar No Rx Required for their potential new product ... Sokwanele Cozaar No Rx - Aug 17, 2007 ...spending an outlay of company Cozaar No Rx * Cozaar No Rx a patent on the legal jurisdiction. Medications are typically produced by pharmaceutical companies ... Sokwanele For Patients with Hypertension and Left Ventricular Hypertrophy, FDA ... - Apr 18, 2005 In March 2003, the FDA approved the same indication for Merck's antihypertensive drug COZAAR(reg) (losartan potassium tablets). HYZAAR and COZAAR are the ... Medical News Today - Medical News Today (press release) Aurobindo's Losartan gets US nod - Aug 22, 2008 Losartan Potassium tablets are the generic equivalent of Merck Research Laboratories' Cozaar tablets and falls in the antihypertensive segment. ... Hindu Business Line Cozaar - High Blood Pressure Medication Review - Dec 29, 2007 Losartan is the generic version for Cozaar and is usually used by medical workers to treat Hypertension. For patients stricken with Type 2 Diabetes, ... Buzzle FDA Approves HYZAAR As the First and Only Fixed-Dose Combination … - Apr 14, 2005 In March 2003, the FDA approved the same indication for Merck's antihypertensive drug COZAAR(R) (losartan potassium tablets). HYZAAR and COZAAR are the only ... RedOrbit Popular drug may hold promise for deadly complication of Marfan … - Apr 6, 2006 The studies published Friday involve only mice, but the drug Cozaar worked so well ... Because Cozaar already is sold as an adult and child hypertension ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Cozaar from Canadian Pharmacy - Aug 5, 2007 ...political implications. To protect the consumer and prevent abuse, many governments regulate the manufacture, sale, and administration of medication. ... Sokwanele Drug association suspends firm for rule violation - Oct 4, 2006 Doctors were offered help from the company in screening blood pressure patients, but the service was only given to physicians who used Cozaar, its blood ... Pay-Per-View - Toronto Star - ProQuest Archiver New 28-day pack for Cozaar launched - Jul 20, 2005 A new 28-day pack of Merck Sharp & Dohme's top-selling hypertension treatment Cozaar has been launched in the UK. The 50mg and 100mg doses of the drug are ... Pharmafocus Discount Cozaar COD - Jun 22, 2007 ...* Carefully research Discount Cozaar COD demand for their potential new medicines typically only one will ever reach the open market, this is an expensive ... Sokwanele Cheap Cozaar No Rx - May 30, 2007 ...and volume of distribution), and pharmacodynamics describes the effect of the Sciences Cheap Cozaar No Rx Cheap Cozaar No Rx - Pharmacology major ... Sokwanele Cozaar helps burden of AF management.(Pharmaceutical industry)(atrial... - Mar 14, 2005 Data from the landmark LIFE study show that Merck & Co's Cozaar (losartan), in a 50mg-100mg daily dosing regimen, significantly lowers the risk of new-onset ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Saving Children's Hearts - Jun 27, 2008 However, a small preliminary study of the drug losartan (Cozaar) on 18 children with Marfan syndrome showed promising results. ... Ivanhoe Broadcast News Merck/NicOx: More Reinvention Rather Than Innovation - Mar 22, 2006 Notwithstanding the lack of innovation, the antihypertensive market was worth $33.1 billion in 2004, with Merck's flagship antihypertensive Cozaar ... RedOrbit Article: Merck's Hyzaar receives clearance for new indication.(RX/ … - May 2, 2005 Hyzaar and Cozaar are the only angiotensin II receptor blockers (ARBs) to be ... Hyzaar is the fixed-dose combination of Cozaar (losartan potassium) and ... Pay-Per-View - Chain Drug Review - HighBeam Research Cozaar.(Drug overview) - Jan 22, 2007 Cozaar is used in the treatment of high blood pressure. It is effective when used alone or with other high blood pressure medications, such as diuretics ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com Boehringer Ingelheim Shrinks Its Sales Force - Sep 22, 2008 That's right, InVentiv signed a deal to market Merck's Cozaar and Hyzaar, which puts Boehringer at an even greater disadvantage, since InVentiv reps will ... Pharmalot Cozaar Comp addition. - Nov 10, 2005 Merck Sharp & Dohme has launched Cozaar Comp 100/25 - a losartan and hydrochlorothiazide combined tablet for blood pressure. Cozaar Comp has been renamed ... $4.95 - Community Pharmacy - ECNext Two-Drug Combo Reduces Diabetic Kidney Damage - Jun 4, 2008 But the researchers warn that testing the combination of losartan (Cozaar) and aliskiren (Tekturna) to block the activity of a molecule that damages renal ... HealthCentral.com OTC: New prescription products - Cozaar Comp 100/25.(Merck Sharp and … - Dec 3, 2005 Tablets containing losartan potassium 100mg and hydrochlorothiazide 25mg. For the treatment of hypertension in patients whose blood pressure has been ... Free with registration - Chemist & Druggist - AccessMyLibrary.com Merck Denies Caving On UK Cozaar Pricing - Aug 18, 2007 By Ed Silverman // August 18th, 2007 // 9:56 am. The drugmaker slashed the price of its blood pressure medication by up to one third in the UK, ... Pharmalot Breaking the rules: three pharma companies reprimanded for promotional... - May 1, 2006 Merck's Cozaar (losartan) is in the latter category, but in a poster distributed to doctors, the company had switched the order of the classes, ... $9.94 - Pharmaceutical Executive - Alacra Store Access for dual eligibles: top brands lose ground. - Apr 1, 2006 For some drugs, like Cozaar (losartan) and Lexapro (escitalopram), the reduction in access is substantial. On the other hand, a few brands, ... $9.94 - Pharmaceutical Executive - Alacra Store Scriptlines: Cozaar 28s.(product introduction)(Brief Article) - Jul 23, 2005 Merck Sharp & Dohme has launched a 28-day pack of Cozaar 25mg tablets (losartan potassium). Price: 28 tablets #18.09 Pip code: 317-0347 Merck Sharp & Dohme ... $4.95 - Chemist & Druggist - ECNext Scripps Howard News Service - Jan 22, 2007 Last year, a team led by Dr. Harry Dietz discovered that treating Marfan mice with the drug losartan, or Cozaar, dramatically strengthens the aorta, ... HNN Huntingtonnews.net Scriptlines: Cozaar Comp 100/25. - Oct 15, 2005 Containing losartan 100mg and hydrochlorthiazide 25mg, the tablets are licensed for treating hypertension in patients whose blood pressure is not adequately ... $4.95 - Chemist & Druggist - ECNext Scientia Veritas announces updates in stroke management. - Feb 9, 2005 Among pharmaceutical products specifically indicated for stroke, both Cozaar and Exanta continue to provide news. In 2003, Cozaar became the first ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Few doctors prescribe medicine for prediabetes - Aug 14, 2007 I told my doctor, and she changed me to Cozaar. Still no luck. ... Cozaar is only losartan. If medicine caused your pain, losartan is the likely culprit. ... SouthCoastToday.com - SouthCoastToday.com Boniva, Hyzaar.(New & Approved) - Jun 1, 2005 Losartan (Cozaar) was approved for this indication in 2003, the only ARB approved ... Recommended Dosage: Start with Cozaar 50 mg once daily, add 12.5 mg of ... Pay-Per-View - Family Practice News - Factiva, from Dow Jones UK parallel traders claim L30M Cozaar/Hyzaar savings for NHS.(Brief … - Sep 3, 2007 As a result of parallel import competition, the UK's National Health service will save an estimated L30.2 million ($60.8 million) per year due to major ... $4.95 - Pharma Marketletter - ECNext MSD launches Cozaar combo drug in UK. - Oct 17, 2005 Merck Sharpe and Dohme, the UK subsidiary of US drug major Merck & Co, has launched a new treatment for hypertension in response to a British Hypertension ... $4.95 - Pharma Marketletter - ECNext OTC: New prescription products - Cozaar Comp 100/25.(Merck Sharp and … - Dec 3, 2005 Tablets containing losartan potassium 100mg and hydrochlorothiazide 25mg. Usual dose: one tablet daily. Merck Sharp & Dohme Ltd. Tel: 01992 467272 ... $4.95 - Chemist & Druggist - ECNext Une plus-value gonfle le résultat du 1er trimestre de Merck - Apr 21, 2008 Les ventes mondiales du traitement contre l'asthme Singulair ont elles bondi de 10% à 1,1 milliard de dollars et celle du médicament pour la tension Cozaar ... Le Point Vioxx loss drags on Merck & Co results.(company sales and … - May 2, 2005 Revenues from the antihypertensives Cozaar (losartan) and Hyzaar (losartan plus hydrochlorothiazide) were also strong, rising 14% to $719.0 million ... Free with registration - Pharma Marketletter - AccessMyLibrary.com HYZAAR(R) 100-12.5 mg Offers A New Convenient Dosing Option Within … - Oct 21, 2005 HYZAAR and COZAAR are the only angiotensin II receptor blockers (ARBs) ... In patients with hypertension, the usual starting dose is COZAAR 50 mg once daily ... $4.95 - Business Wire - ECNext Scriptlines: Cozaar for kids - Dec 31, 2005 The addition to the SPC's prescribing and tolerability sections was made following a trial involving 177 paediatric patients with hypertension. ... Pay-Per-View - Chemist & Druggist - Factiva, from Dow Jones Scriptlines: Cozaar for kids.(Merck Sharp and Dohme Ltd.)(Brief... - Dec 31, 2005 The addition to the SPC's prescribing and tolerability sections was made following a trial involving 177 pediatric patients with hypertension. ... $4.95 - Chemist & Druggist - ECNext Woman accused of stealing medication - Oct 25, 2005 Huynh-Le took Zocor, Triglide, Protonix, Plavix, Cozaar, Crestor and Lipitor, police said. The retail value of the drugs is estimated around $9000. ... Pay-Per-View - Morning Call - ProQuest Archiver FDA Approves HYZAAR(R) as First/Only Fixed-Dose Combination … - May 16, 2005 In March 2003, the FDA approved the same indication for Merck's antihypertensive drug COZAAR(R) (losartan potassium tablets). HYZAAR and COZAAR are the only ... Medical News Today - Medical News Today (press release) FDA Approves HYZAAR as the First and Only Fixed-Dose Combination … - Apr 14, 2005 HYZAAR and COZAAR are the only angiotensin II receptor blockers (ARBs) to be ... HYZAAR is the fixed dose combination of COZAAR (losartan potassium) and ... $4.95 - Business Wire - ECNext Pressured by patent expirations, new hypertension solutions found. - Aug 13, 2007 In 2006, just the top three performing hypertension drugs--Norvasc, Diovan and Cozaar/Hyzaar--reaped sales of more than $12 billion, according to data from ... $9.94 - Drug Store News - Alacra Store 默沙东第一å£ç›ˆåˆ©è¶…预期è?¥æ”¶ä¸?足 - Apr 21, 2008 ...较è€?的高血压è?¯ç‰©Cozaarå’ŒHyzaar的销售总é¢?ä¿?æŒ?增长，涨幅为6%，至8.47亿美元。 与æ¤å?Œæ—¶ï¼ŒFosamax的销售é‡?è·Œ37%，至4.7亿美元。 默沙东指出，胆固醇控制è?¯ç‰©Vytorin ... 新浪网 Merck publie une hausse de son bénéfice trimestriel - Jul 23, 2007 Celles du Cozaar et de l'Hyzaar, deux médicaments contre l'hypertension, affichent une hausse de 8% à 847 millions. Le Januvia, un nouvel antidiabétique ... nouvelobs.com La farmacéutica Merck anuncia 7.000 despidos, la mitad en EE UU - Nov 29, 2005 El grupo también espera una caÃda en las ventas de Fosamax (contra la osteoporosis), mientras que prevé que se mantengan estables en el caso del Cozaar ... El PaÃs - El PaÃs (España) LUCRO DA MERCK SOBE 12% E SUPERA PREVISÕES DOS … - Jul 23, 2007 As vendas do remédio da empresa contra a asma ea alergia Singulair cresceram 15%, para 1,1 bilhão, enquanto as dos medicamentos para a hipertensão Cozaar e ... G1.com.br Novartis's Tekturna restricts heart enlargement - Mar 31, 2008 Tekturna, whether taken alone or in combination with Cozaar, was well tolerated and showed a very low level of adverse events. Cozaar was co-developed by ... Reuters India LUCRO DA MERCK SUBIU 12% NO PRIMEIRO TRIMESTRE - Apr 19, 2007 No caso dos remédios Cozaar e Hyzaar2, para o tratamento da hipertensão, as vendas conjuntas chegaram a US$ 798 milhões, o que representa um aumento de 14% ... G1.com.br Merck: légère hausse du BPA au 2è trimestre. - Jul 22, 2008 1,1 milliard de dollars, mais celles des traitements contre l'hypertension Cozaar et Hyzaar ont progressé de 11% pour atteindre 941 millions de dollars. ... Bolsamania.fr Давление падает – мышцы раÑ?тут - Jan 24, 2007 больных Ñ?индромом Марфана, при приёме лозартана (losartan) или козаара (Cozaar) прекращали раÑ?ширÑ?Ñ‚ÑŒÑ?Ñ? артерии и резко Ñ?нижалÑ?Ñ? риÑ?к аневризмы аорты. ... Газета.Ru Cozaar og hodepine - Nov 3, 2005 Hei, jeg er en kvinne pÃ¥ 51 Ã¥r som i over 10 Ã¥r har fÃ¥tt behandling mot høyt blodtrykk. Det siste ca. halvannet Ã¥ret har jeg brukt Cozaar 50 mg. ... Lommelegen.no EconomÃa/Empresas.- Merck gana un 94% más en el primer trimestre y … - Apr 21, 2008 ...acción de entre 3,84 y 4 dólares (2,41 y 2,51 euros) y un incremento de los ingresos por las ventas de Singulair, Cozaar, Gardasil, Fosamax y vacunas. elEconomista.es Blood-pressure drug touted as possible savior for Marfan sufferers: … - Apr 7, 2006 The studies being published Friday are only in mice, but the drug Cozaar worked so ... Cozaar is the first medicine thought to possibly block the disease's ... Pay-Per-View - Chicago Sun-Times - HighBeam Research Micardis лучше защищает почки, чем Cozaar - Sep 3, 2007 18 июнÑ? компаниÑ? «Boehringer Ingelheim» на заÑ?едании ЕвропейÑ?кого общеÑ?тва гипертензии (European Society of Hypertension) в Милане (ИталиÑ?) были ... Ð?птека online Merck: Bottomed out or still at risk? - Apr. 6, 2006 - Apr 6, 2006 Cozaar loses its patent in 2009. Analysts are mixed as to whether Merck can fill the sales vacuum when Zocor goes generic. The company's pipeline -- drugs ... CNNMoney.com NU IN DE WINKEL - Oct 1, 2008 De huisarts schreef Cozaar. 100 mg voor. Mijn man vertelde dat wij duikers zijn en dit graag blijven doen. Volgens de huisarts geeft dit medicijn de minste ... Duiken MERCK voit ses résultats progresser et ses effectifs diminuer - Dec 4, 2007 Le groupe pharmaceutique dispose de médicaments phares : le Zocor, un anti-cholestérol, le Fosamax (contre l'ostéoporose), le Cozaar et Hyzaar (contre ... Capital.fr BLOOD PRESSURE DRUG MAY HELP PREVENT MARFAN SIDE … - Apr 10, 2006 The blood pressure drug Cozaar (losartan) may help prevent a serious ... Cozaar, the preclinical study found, could decrease the risk of this aortal damage. ... Pay-Per-View - Daily International Pharma Alert - Factiva, from Dow Jones Merck eleva un 12% su beneficio pese al impacto de las demandas por... - Jul 23, 2007 ...su medicamento contra el asma y la alergia Singulair, mientras las de sus drogas para la alta presión, Cozaar y Hyzaar, crecieron un 8% a 847 millones. ... Bolsacinco.com Invertia.com - mercados,finanzas,economÃa, fondos y cotizaciones - Jan 25, 2005 Los ingresos por la venta de Cozaar progresarán 300 millones de dólares, hasta los 3.200 millones de dólares (2.470 millones de euros), la misma subida que ... Invertia Studio COURAGE: nessun beneficio del PCI sulla terapia medica... - Apr 12, 2007 ...ed Isosorbide mononitrato ( Monoket ) da solo o in combinazione a Lisinopril ( Zestril ) o Losartan ( Lortaan / Cozaar ) come prevenzione secondaria. ... XagenaSalute ФинанÑ?овые новоÑ?ти архив ВыпуÑ?к новых препаратов Ñ?поÑ?обÑ?тво - Apr 19, 2007 Продажи антигипертензивного препарата Cozaar выроÑ?ли на 14% до $798 млн. Объем продаж противохолеÑ?териновых Ñ?редÑ?тв Zetia и Vitorin, разработанных Ñ?овмеÑ?тно ... K2Kapital Merck Announces Third-Quarter 2005 Earnings Per Share (EPS) of 65 … - Oct 24, 2005 Global sales of Merck's antihypertensive medicines, COZAAR and HYZAAR*, ... COZAAR and HYZAAR belong to the AIIA class, which remains the fastest growing ... Free with registration - Business Wire - AccessMyLibrary.com Merck Announces First-Quarter 2005 Earnings Per Share -EPS- of 62 … - Apr 21, 2005 US mail-order-adjusted prescription levels for COZAAR and HYZAAR were in line with ... COZAAR and HYZAAR compete in the fastest-growing class in the ... Free with registration - Business Wire - AccessMyLibrary.com Article: Merck study: No extra heart, stroke risk in year after Vioxx... - May 11, 2006 Cholesterol treatment Zocor, pain reliever Vioxx and blood pressure medicines Cozaar and ... Bextra, a new competitor to Merck's Vioxx, that he believes ... Pay-Per-View - AP Worldstream - HighBeam Research New York Miscellaneous Reports - WALSH v. AVERBUKH, 0100005/ … - Dec 10, 2007 See Page 3 Shepard EBT, p27 It appears from the records of Memorial Sloan Kettering Hospital that Cozaar had been previously prescribed there for Walsh's ... Pay-Per-View - New York Miscellaneous Reports - Loislaw Revamping at Merck to Cut Costs - Nov 29, 2005 Fosamax is Merck's second-largest selling medicine, while Cozaar is fourth. "Has the outlook really changed? The answer is no," said David Moskowitz, ... New York Times Global top 300 brand-name pharmaceuticals by sales, manufacturer, and... - Apr 28, 2008 Tussionex 53014054867 178 MSD Cozaar 00006095254 179 Tap Pharm. ... Byetta 66780021007 221 MSD Cozaar 00006096031 222 Sanofi Pharm. ... $20.00 - Chain Drug Review - Alacra Store DuPont Shares Look 'Deceptively Cheap' - Jan 12, 2006 The 2010 patent expirations of Cozaar and Hyzaar, developed with Merck (nyse: MRK - news - people ), will cut operating income by $800 million, ... Forbes - Analysts See Potential Hurdles For Merck - Dec 6, 2006 In particular, he pointed out that Cozaar loses its patent in the US and Europe in 2010. In 2012, Singulair goes off patent and, at some point between 2010 ... Forbes Merck, Schering-Plough Profit From Joint Venture - Jul 24, 2007 Also, generic competition looms for Merck blockbusters Fosamax, an osteoporosis treatment, and Cozaar, a hypertension drug, because they are expected to ... Wall Street Journal Merck Announces Strong Financial Results for the First Quarter 2006 - Apr 20, 2006 Global sales of Merck's antihypertensive medicines, COZAAR and HYZAAR, ... COZAAR/HYZAAR remained the number one branded AIIA in Europe and number two ... SmartBrief 抗高血压è?¯ç‰©å¸‚场预测 - Jan 25, 2007 ...é?¢å¯¹è¯¥ç§?类的较新的化å?ˆç‰©ï¼ŒCozaar（氯沙å?¦ï¼‰ä¼šå¤±åŽ»å¸‚场份é¢?。 ... 但是Cozaarä»?然å?— 销售力é‡?和默克公å?¸é”€å”®ç»?验的支æŒ?，将会继ç»äº§ç”Ÿå¤§é‡?的销售é¢?，其市场份é¢?比其它 ... 金èž?ç•Œ Forest Laboratories, Inc. at Deutsche Bank Securities Inc. Health... - May 3, 2005 COZAAR, which is the Merck product, COZAAR and HYZAAR continue to lose share -- lose significant share in this marketplace -- and based on the trends that ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Nursing Drugmakers Back To Health - May 30, 2007 The watchdog body found that Merck had instructed its sales reps to offer the program to doctors who were big prescribers of Cozaar, making the program a ... Pharmalot Questions and Answers on Hypertension Control - Dec 31, 2007 I am taking Cozaar for high blood pressure. Some days my readings aren't too bad but ... I wonder if the intake of Potassium will interact with the Cozaar. ... HealthCentral.com Lipitor in decline as PCTs take control - May 9, 2008 Nevertheless, despite the fall in prescriptions for Cozaar the drug's higher price allowed MSD to retain the lion's share of sales - £93 million compared to ... Pharmafocus Event Brief of Q2 2007 DuPont Earnings Conference Call - Final. - Jul 24, 2007 Cozaar business added $0.03. 1. Reflects ongoing collaboration with Merck and strong 2Q07 Cozaar sales reported by Merck. 2. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com DuPont reports double-digit increase in first-quarter earnings - Apr 24, 2007 The company noted that US exclusivity for Cozaar ends in April 2010. Meanwhile, sales in both the US housing and automotive markets were down about $100 ... San Diego Union - Tribune - San Diego Union Tribune Bivirkninger av medisin ? - Aug 21, 2006 Jeg tar Cozaar forte og Zanidip10 mg for for høyt blodtrykk og har gjort dette i 4mnd . ... Du bruker altsÃ¥ Cozaar forte og Zanidip mot høyt blodtrykk, ... Lommelegen.no Company Profile Report - Apr 5, 2008 Cozaar (Losartan Potassium). Non-Insulin Dependent Diabetes Mellitus (NIDDM)/Type 2 Diabetes. Biguanides/Dipeptidyl Peptidase (DPP) Inhibitors ... $50.00 - Revere Reports - Revere Merck Cuts To Have Minimal NJ Impact - Oct 22, 2008 With the exception of Pfizer, Merck is facing more generic competition than other drug makers, Conover says, adding that patents for Cozaar and Hyzaar will ... NJBIZ EU Panel Backs Wider Approval Of Merck's Erbitux - Oct 24, 2008 Cozaar and associated names are authorised at the level of the Member States. This is the first recommendation for a line-extension relating to a new ... Capital.gr DuPont's Holliday Says US Recession Is Unlikely - Dec 11, 2007 Hypertension treatments Cozaar and Hyzaar, marketed through Merck & Co., lose US patent protection in 2010. They added $819 million to DuPont's profit last ... Bloomberg DuPont invests in its Laurels - In reorganizing, the chemical giant... - Apr 9, 2006 In the last 15 years, DuPont has had a couple of home runs - high-blood-pressure medication Cozaar in the mid-1990s, which the company commercialized with ... $2.95 - Philadelphia Inquirer - NewsBank 心血管系统畅销è?¯ç‰©å“?ç§?ç ”ç©¶åˆ†æž? - Sep 21, 2006 ...洛沙å?¦é’¾ï¼ˆlosartan，商å“?å??：Cozaar ç§‘ç´ äºšï¼‰æœ¬å“?为第一个新型的沙å?¦ç±»æŠ—高血压 ... 洛沙å?¦é’¾ï¼ˆcozaar）å?Šæ´›æ²™å?¦é’¾ï¼?å?Œæ°¢å…‹å°¿å™»ï¼ˆHyzaar）å¤?方片剂于1996å¹´12月25æ—¥ ... 金èž?ç•Œ Brand Names/Synonyms: Cozaar is also known by the following brand names and/or synonymsCHEMBANK1667; Cozaar; DUP 89; Hyzaar; Lacidipine; Lortaan; Losartan Drug Category: Cozaar is categorized under the following by the FDA: Antihypertensive Agents; Antiarrhythmic Agents; Angiotensin II Receptor Antagonists; ATC:C09CA01 Dosage Forms: Tablets Absorption: Well absorbed, the systemic bioavailability of losartan is approximately 33% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-3H-imidazol-4-yl]methanol |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |